Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotechnologies Reports Second Quarter 2017 Results

NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter...
August 02, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis

NEW YORK, Aug. 02, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a...
July 20, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Enters Services Agreement With Israel-Based CRO to Begin Clinical POC Study on CBD and Gabapentin Chewing Gum for Treatment of Restless Leg Syndrome

NEW YORK, July 20, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a...
July 12, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Holds Bi-Annual Board Meeting in New York City on July 8

NEW YORK, July 12, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, announced today that it held its bi-annual...
June 23, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with...
June 19, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM® Biotechnologies Secures Funding to Advance Clinical Trials and Bioequivalency Study

NEW YORK, June 19, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company has...
June 14, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech to Present at 2017 Marcum Microcap Conference in New York City

NEW YORK, June 14, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George Anastassov,...
June 01, 2017 09:30 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech to Present at 6th Annual SeeThruEquity Microcap Investor Conference in New York City

NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George Anastassov,...
May 23, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech to Present Research Abstracts at the 6th Pharmaceutical Sciences World Congress

NEW YORK, May 23, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Lekhram Changoer,...
May 16, 2017 10:00 ET | Source: AXIM Biotechnologies, Inc

SeeThruEquity Initiates Coverage on AXIM® Biotechnologies (OTC: AXIM) With a Target Price of $17.0

NEW YORK, May 16, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that SeeThruEquity, a...